Eficacia y seguridad de la terapia con inhibidores de la PCSK9 en el tratamiento de las dislipidemias y riesgo cardiovascular
Dyslipidemia, defined as an alteration in blood lipid levels. In particular, cholesterol and triglycerides are a key risk factor for cardiovascular health. Protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are mechanisms used to treat diseases related to excess cholesterol in the blood....
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | bachelorThesis |
| Lingua: | spa |
| Pubblicazione: |
2025
|
| Soggetti: | |
| Accesso online: | https://dspace.uniandes.edu.ec/handle/123456789/19185 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Aggiungi Tag